Status: current, Defined. Date: 31-Oct 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4632831000168118 | Darzalex SC (daratumumab 1.8 g / 15 mL) injection, 15 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4632841000168110 | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Is a | Darzalex SC | true | Inferred relationship | Some | ||
| Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Is a | daratumumab 1.8 g/15 mL injection, vial | true | Inferred relationship | Some | ||
| Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Darzalex SC 1.8 g/15 mL injection, 15 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Darzalex SC 1.8 g/15 mL injection, 15 mL vial | has intended active ingredient | daratumumab | true | Inferred relationship | Some | 612652602 | |
| Darzalex SC 1.8 g/15 mL injection, 15 mL vial | has Australian BoSS | daratumumab | true | Inferred relationship | Some | 612652602 | |
| Darzalex SC 1.8 g/15 mL injection, 15 mL vial | has unit of use | vial | true | Inferred relationship | Some | 966405879 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Darzalex SC 1.8 g/15 mL injection, 15 mL vial | has TPUU | True | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Inferred relationship | Some | 847098533 |
| Darzalex SC 1.8 g/15 mL injection, 15 mL vial | has TPUU | True | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Inferred relationship | Some | 933755236 |
Reference Sets
Trade product unit of use reference set
FHIR